Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124265622 | 12426562 | 2 | F | 20130809 | 20160922 | 20160601 | 20160928 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-34364BI | BOEHRINGER INGELHEIM | 68.94 | YR | M | Y | 325.00000 | KG | 20160928 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124265622 | 12426562 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | N | 22512 | 150 | MG | CAPSULE | BID | |||||
| 124265622 | 12426562 | 2 | C | EPOGEN | ERYTHROPOIETIN | 1 | Unknown | STRENGTH: 20,000 UNIT/ML; FORMULATION: INJECTION | 0 | 1 | ML | ||||||||
| 124265622 | 12426562 | 3 | C | DULERA | FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE | 1 | Oral | 4 PUF | 0 | BID | |||||||||
| 124265622 | 12426562 | 4 | C | CLARITIN | LORATADINE | 1 | Unknown | 0 | 10 | MG | |||||||||
| 124265622 | 12426562 | 5 | C | DILTIAZEM HCL | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 120 MG | 0 | 60 | MG | TABLET | BID | ||||||
| 124265622 | 12426562 | 6 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 240 MG | 0 | 120 | MG | CAPSULE | BID | ||||||
| 124265622 | 12426562 | 7 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 60 MG | 0 | 60 | MG | CAPSULE | QD | ||||||
| 124265622 | 12426562 | 8 | C | DIGITEK | DIGOXIN | 1 | Oral | 250 MCG | 0 | 250 | UG | TABLET | QD | ||||||
| 124265622 | 12426562 | 9 | C | LISINOPRIL- HYDROCHLOROTHIAZIDE | 2 | Oral | DOSE PER APPLICATION AND DAILY DOSE: 20-12.5 MG | 0 | TABLET | QD | |||||||||
| 124265622 | 12426562 | 10 | C | ASA | ASPIRIN | 1 | Oral | 325 MG | 0 | 325 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124265622 | 12426562 | 1 | Atrial fibrillation |
| 124265622 | 12426562 | 2 | Product used for unknown indication |
| 124265622 | 12426562 | 3 | Product used for unknown indication |
| 124265622 | 12426562 | 4 | Product used for unknown indication |
| 124265622 | 12426562 | 5 | Product used for unknown indication |
| 124265622 | 12426562 | 6 | Product used for unknown indication |
| 124265622 | 12426562 | 8 | Product used for unknown indication |
| 124265622 | 12426562 | 9 | Product used for unknown indication |
| 124265622 | 12426562 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124265622 | 12426562 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124265622 | 12426562 | Acute kidney injury | |
| 124265622 | 12426562 | Asthenia | |
| 124265622 | 12426562 | Coagulopathy | |
| 124265622 | 12426562 | Haemorrhagic anaemia | |
| 124265622 | 12426562 | Upper gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124265622 | 12426562 | 1 | 20110621 | 0 | ||
| 124265622 | 12426562 | 2 | 20130820 | 0 | ||
| 124265622 | 12426562 | 3 | 20120515 | 0 | ||
| 124265622 | 12426562 | 5 | 20100518 | 0 | ||
| 124265622 | 12426562 | 6 | 20080514 | 0 | ||
| 124265622 | 12426562 | 7 | 20070430 | 0 | ||
| 124265622 | 12426562 | 8 | 20040614 | 0 | ||
| 124265622 | 12426562 | 9 | 20040603 | 0 | ||
| 124265622 | 12426562 | 10 | 20070430 | 0 |